STEPHANIE O'HALLORAN-WILKERSON: Open Payments
NPI 1811630494 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 53 payments from 10 companies in 2025. Trend: 2023 $554 · 2024 $466 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $184 |
| E.R. Squibb & Sons, L.L.C. | 9 | $175 |
| Janssen Pharmaceuticals, Inc | 7 | $155 |
| Vanda Pharmaceuticals Inc. | 6 | $140 |
| Axsome Therapeutics, Inc. | 2 | $139 |
| Otsuka America Pharmaceutical, Inc. | 4 | $104 |
| ABBVIE INC. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
| Lundbeck LLC | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
Products named: COBENFY, Auvelity, HETLIOZ, UZEDY, ABILIFY ASIMTUFII, INVEGA SUSTENNA, VRAYLAR, AUSTEDO XR.
Industry payments across MO — which companies pay providers there.
